Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The impact of pharmacogenetics on the development and use of antipsychotic drugs.

Drug discovery today - 1 Nov 2007

Reynolds Gavin P

Abstract excerpt

There are substantial differences between individuals in the effects of antipsychotic drugs in the treatment of schizophrenia. This is apparent in symptom response, as well as in the emergence of side effects, such as tardive dyskinesia or weight gain. Genetic variation is likely to contribute su...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Drug Design
Share to Pharmacogenetics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Polymorphism, Genetic

Share to Schizophrenia

Source

Identifiers

PMID: 17993414
DOI: 10.1016/j.drudis.2007.07.018

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17993414-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The impact of pharmacogenetics on the development and use of antipsychotic drugs.PMID 17993414Read ↗

The pharmacogenetics of antipsychotic treatment.Semantic proximity Read ↗

Pharmacogenetics and schizophrenia.Semantic proximity Read ↗

Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction.Semantic proximity Read ↗

Pharmacogenetics of antipsychotics: Clinical utility and implementationSemantic proximity Read ↗

Pharmacogenetics and outcome with antipsychotic drugsSemantic proximity Read ↗

Clinical Utility and Implementation of Pharmacogenomics for the Personalisation of Antipsychotic TreatmentsSemantic proximity Read ↗

Genomics and the future of pharmacotherapy in psychiatrySemantic proximity Read ↗

Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine.Semantic proximity Read ↗

Pharmacogenetics of Response to Antipsychotics in Patients with SchizophreniaSemantic proximity Read ↗

Pharmacogenetics of AntipsychoticsSemantic proximity Read ↗

Toward understanding genetic risk for differential antipsychotic response in individuals with schizophreniaSemantic proximity Read ↗

Pharmacogenetics of antipsychotics: recent progress and methodological issuesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.